Literature DB >> 1919868

Necrotizing myopathy in critically-ill patients.

T R Helliwell1, J H Coakley, A J Wagenmakers, R D Griffiths, I T Campbell, C J Green, P McClelland, J M Bone.   

Abstract

Skeletal muscle wasting is commonly observed in critically-ill patients and has been attributed to catabolic fibre atrophy and to neuropathy. This study describes the occurrence of a necrotizing myopathy in 15 out of 31 critically-ill patients who had percutaneous biopsies taken from the tibialis anterior muscles. While most cases showed necrosis of isolated fibres, 5 of the 12 patients who had serial biopsies showed progressive necrosis of up to 95 per cent of the fibres. One other case showed infarction and one case had staphylococcal vasculitis. Atrophy of type 1 and/or type 2 fibres was documented by morphometry in 12 cases. Myoglobin-containing casts were demonstrated immunohistochemically in renal tubules on either biopsy or necropsy material in 5 out of 7 cases. The presence of muscle necrosis was a clinically unexpected finding which may contribute to weakness, complicate the interpretation of tissue biochemistry and energy balance studies, and potentiate renal failure. The necrosis is probably multifactorial in origin, with ischaemia and sepsis contributing factors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919868     DOI: 10.1002/path.1711640406

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

Review 1.  Neuromuscular transmission and its pharmacological blockade. Part 4: Use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 2.  Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.

Authors:  Christian R Osadnik; Vanessa S Tee; Kristin V Carson-Chahhoud; Joanna Picot; Jadwiga A Wedzicha; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2017-07-13

3.  Risk factors for critical illness polyneuromyopathy.

Authors:  J Bednarík; P Vondracek; L Dusek; E Moravcova; I Cundrle
Journal:  J Neurol       Date:  2005-03-30       Impact factor: 4.849

4.  Novel events in the molecular regulation of muscle mass in critically ill patients.

Authors:  Despina Constantin; Justine McCullough; Ravi P Mahajan; Paul L Greenhaff
Journal:  J Physiol       Date:  2011-06-13       Impact factor: 5.182

Review 5.  Neuromuscular blocking drugs: practical aspects of research in the intensive care unit.

Authors:  N J Harper
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 6.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

7.  Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis.

Authors:  J H Coakley; K Nagendran; M Honavar; C J Hinds
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

8.  Critical illness polyneuromyopathy: the electrophysiological components of a complex entity.

Authors:  Josef Bednarik; Zdenek Lukas; Petr Vondracek
Journal:  Intensive Care Med       Date:  2003-07-17       Impact factor: 17.440

Review 9.  Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers.

Authors:  Margaret S Herridge; Marc Moss; Catherine L Hough; Ramona O Hopkins; Todd W Rice; O Joseph Bienvenu; Elie Azoulay
Journal:  Intensive Care Med       Date:  2016-03-30       Impact factor: 17.440

10.  Patterns of neurophysiological abnormality in prolonged critical illness.

Authors:  J H Coakley; K Nagendran; G D Yarwood; M Honavar; C J Hinds
Journal:  Intensive Care Med       Date:  1998-08       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.